Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 27% ± 8% | |
oligodendrocyte precursor cell | 9 studies | 29% ± 13% | |
endothelial cell of lymphatic vessel | 6 studies | 31% ± 7% | |
fibroblast | 5 studies | 23% ± 7% | |
capillary endothelial cell | 4 studies | 24% ± 7% | |
retinal cone cell | 4 studies | 26% ± 12% | |
astrocyte | 4 studies | 33% ± 13% | |
vein endothelial cell | 3 studies | 37% ± 18% | |
endothelial cell of vascular tree | 3 studies | 35% ± 18% | |
hepatocyte | 3 studies | 53% ± 21% | |
glutamatergic neuron | 3 studies | 21% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1283.06 | 1442 / 1445 | 100% | 12.76 | 183 / 183 |
breast | 100% | 1539.43 | 459 / 459 | 96% | 10.16 | 1070 / 1118 |
liver | 100% | 1492.46 | 226 / 226 | 95% | 13.20 | 386 / 406 |
lung | 100% | 1648.05 | 577 / 578 | 94% | 7.05 | 1090 / 1155 |
bladder | 100% | 1695.76 | 21 / 21 | 94% | 7.23 | 473 / 504 |
thymus | 100% | 1078.35 | 650 / 653 | 93% | 7.55 | 564 / 605 |
intestine | 99% | 1528.36 | 960 / 966 | 93% | 7.23 | 490 / 527 |
kidney | 100% | 970.51 | 89 / 89 | 89% | 10.39 | 801 / 901 |
uterus | 100% | 1584.89 | 170 / 170 | 88% | 6.72 | 405 / 459 |
prostate | 100% | 1130.00 | 244 / 245 | 87% | 5.16 | 438 / 502 |
stomach | 90% | 857.77 | 323 / 359 | 95% | 8.10 | 272 / 286 |
adrenal gland | 99% | 884.43 | 255 / 258 | 86% | 5.03 | 197 / 230 |
skin | 100% | 3336.42 | 1807 / 1809 | 84% | 6.72 | 398 / 472 |
pancreas | 51% | 230.95 | 166 / 328 | 92% | 5.26 | 163 / 178 |
ovary | 100% | 831.87 | 180 / 180 | 38% | 1.34 | 165 / 430 |
brain | 43% | 190.44 | 1140 / 2642 | 94% | 6.98 | 661 / 705 |
adipose | 100% | 1523.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2041.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 12534.55 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 776.64 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 675.75 | 828 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 7.10 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.62 | 13 / 29 |
peripheral blood | 45% | 302.38 | 414 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 1.40 | 32 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0031623 | Biological process | receptor internalization |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0048814 | Biological process | regulation of dendrite morphogenesis |
GO_0034644 | Biological process | cellular response to UV |
GO_0045087 | Biological process | innate immune response |
GO_0046755 | Biological process | viral budding |
GO_0031175 | Biological process | neuron projection development |
GO_0007041 | Biological process | lysosomal transport |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_0030948 | Biological process | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO_1901016 | Biological process | regulation of potassium ion transmembrane transporter activity |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0034765 | Biological process | regulation of monoatomic ion transmembrane transport |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0042921 | Biological process | nuclear receptor-mediated glucocorticoid signaling pathway |
GO_0050807 | Biological process | regulation of synapse organization |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0010766 | Biological process | negative regulation of sodium ion transport |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0046824 | Biological process | positive regulation of nucleocytoplasmic transport |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_2000650 | Biological process | negative regulation of sodium ion transmembrane transporter activity |
GO_0044111 | Biological process | formation of structure involved in a symbiotic process |
GO_0051592 | Biological process | response to calcium ion |
GO_0032801 | Biological process | receptor catabolic process |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0016327 | Cellular component | apicolateral plasma membrane |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0070063 | Molecular function | RNA polymerase binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0070064 | Molecular function | proline-rich region binding |
GO_0031698 | Molecular function | beta-2 adrenergic receptor binding |
GO_0019871 | Molecular function | sodium channel inhibitor activity |
GO_0050816 | Molecular function | phosphothreonine residue binding |
GO_0050815 | Molecular function | phosphoserine residue binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NEDD4 |
Protein name | NEDD4 E3 ubiquitin protein ligase E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4) HECT-type E3 ubiquitin transferase (EC 2.3.2.26) |
Synonyms | RPF1 PIG53 NEDD4-1 KIAA0093 |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Specifically ubiquitinates 'Lys-63' in target proteins . Involved in the pathway leading to the degradation of VEGFR-2/KDFR, independently of its ubiquitin-ligase activity. Monoubiquitinates IGF1R at multiple sites, thus leading to receptor internalization and degradation in lysosomes (By similarity). Ubiquitinates FGFR1, leading to receptor internalization and degradation in lysosomes . Promotes ubiquitination of RAPGEF2 . According to PubMed:18562292 the direct link between NEDD4 and PTEN regulation through polyubiquitination described in PubMed:17218260 is questionable. Involved in ubiquitination of ERBB4 intracellular domain E4ICD (By similarity). Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development (By similarity). Ubiquitinates TNK2 and regulates EGF-induced degradation of EGFR and TNF2 . Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1 . Ubiquitinates DAZAP2, leading to its proteasomal degradation . Ubiquitinates POLR2A . Functions as a platform to recruit USP13 to form an NEDD4-USP13 deubiquitination complex that plays a critical role in cleaving the 'Lys-48'-linked ubiquitin chains of VPS34 and then stabilizing VPS34, thus promoting the formation of autophagosomes . .; FUNCTION: (Microbial infection) Involved in the ubiquitination of Ebola virus protein VP40 which plays a role in viral budding. . |
Accessions | ENST00000435532.8 [P46934-4] ENST00000506154.1 [P46934-2] ENST00000503468.5 P46934 ENST00000648451.1 A0A3B3IUC1 H0Y9L1 ENST00000508342.5 [P46934-1] H0Y8X6 ENST00000502612.5 ENST00000507063.1 H0YA37 ENST00000508871.5 ENST00000338963.6 [P46934-3] H0Y8H4 |